tirzepatide zepbound mounjaro FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide - Wikipedia

The decision to initiate canagliflozin should be individualised, taking into account the patient's HbA1c levels, cardiovascular risk profile, renal function, and treatment goals

87E44E52

Marchetti, C., Obert, G., Deffosez, A., Formstecher, P

Gastrointestinal issues: Many GLP-1 supplements contain high amounts of fiber or other compounds that, especially when introduced suddenly or in large doses, can cause gastrointestinal discomfort, such as bloating, gas, and digestive upset

They start too high, increase too fast, or stay too long at a dose that isnt moving the needle anymore

Soung AL, Vanderheiden A, Nordvig AS, Sissoko CA, Canoll P, Mariani MB, et al